Sign up
Healthed-White-on-Blue

What Allergy & Anaphylaxis Australia (A&AA) can do for GPs and their patients

Maria Said AM

writer

Maria Said AM

Registered Nurse; CEO of Allergy & Anaphylaxis Australia; Associate member of the Australasian Society of Clinical Immunology and Allergy

Maria Said AM
Maria Said AM

What can Allergy & Anaphylaxis Australia (A&AA) do for your patients?

  • – Individual allergy management advice from trained health professionals on our telephone helpline
  • – Website educational resources
  • – Free subscription to A&AA provides food recalls, e-newsletters and other updates to your patient’s email inbox

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Ralph Audehm & Prof Jeremy Grummet

A/Prof Ralph Audehm & Prof Jeremy Grummet

New Prostate Cancer Screening Guidelines – Case-Based Explanation for GP

Dr Katherine Spira

Dr Katherine Spira

Acute Migraine Management

A/Prof Gary Kilov AM

A/Prof Gary Kilov AM

Continuous Glucose Monitoring Update – Why it will Soon Become Standard Care

Dr Aviv Pudipeddi & Dr David Lim

Dr Aviv Pudipeddi & Dr David Lim

Faecal Calprotectin – A Practical Guide to the Test and the New Item Number

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

01 September 2026
Register Now

Share this

Share this

Maria Said AM

writer

Maria Said AM

Registered Nurse; CEO of Allergy & Anaphylaxis Australia; Associate member of the Australasian Society of Clinical Immunology and Allergy

Test your knowledge

  • Cardiology, Integrative medicine

ECG Quiz | 79-year-old male presents with intermittent palpitations and smartwatch detecting irregular pulse rate

Recent articles

  • Paediatrics, Politics

Social media’s tobacco moment has arrived

  • Endocrinology, Lifestyle

Personalising obesity pharmacotherapy through dose escalation: Insights from the STEP UP trial

  • Accreditation

New mandatory criteria for AI use laid out in updated accreditation standards

  • Policy

Could racism be driving IMGs away? Many GPs think so

Latest GP poll

To what extent do you attribute the current political climate to experiences of racial/ethnic discrimination?

A great extent

0%

A moderate extent

0%

Slightly

0%

Not at all

0%

Read the full story >>

Recent podcasts

Listen to expert interviews.
Click to open in a new tab

AdobeStock_1323026335

Screens, speech and mealtimes: What GPs need to watch out for in early childhood – Part 1

Podcasts iconPodcasts
Closing the Referral Gap with AI

Matching the right practitioner to the right patient with AI

Podcasts iconPodcasts
AdobeStock_91502721

Applying the new WHO dementia risk reduction guidelines in midlife general practice

Podcasts iconPodcasts
AdobeStock_2086999225

Managing obesity: Integrating GLP‑1 therapy with bariatric surgery

Podcasts iconPodcasts

Find your area of interest

Next up

Browse the latest articles from Healthed.

View more
Paediatrics, Politics

Social media's tobacco moment has arrived

Meta settles landmark US lawsuit for nearly $18bn and agrees to change Facebook and Instagram.

Endocrinology, Lifestyle

Personalising obesity pharmacotherapy through dose escalation: Insights from the STEP UP trial

How increasing GLP-1 dose can improve weight loss and health outcomes without risking safety..

Discover

Healthed

CPD platform

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Cancel
Confirm & learn

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Register for webcast